SCHEMBL7993333

SCHEMBL7993333

COc1cc(C(C)(C)C)ccc1C(=O)Nc1cccc2c1CCN(C)C2C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H4 Q96RI1 4/20 0.45
ALDH1A1 P00352 4/20 0.42
DHODH Q02127 3/20 0.42
MAPT P10636 3/20 0.42
LMNA P02545 2/20 0.42
HPGD P15428 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
HTT P42858 1/20 0.42
GPR6 P46095 1/20 0.42
PPARG P37231 2/20 0.41
PPARA Q07869 2/20 0.41
KDM4E B2RXH2 3/20 0.40
NPSR1 Q6W5P4 2/20 0.40
TDP1 Q9NUW8 1/20 0.40
MEN1 O00255 1/20 0.39
POLB P06746 1/20 0.39
KMT2A Q03164 1/20 0.39
MAPK14 Q16539 2/20 0.39
NPY1R P25929 1/20 0.39
NPY2R P49146 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7008451 0.83 GPR6 (0.43) NR1H4ALDH1A1DHODHMAPTLMNA
SCHEMBL8185705 0.83 MEN1 (0.47) NR1H4ALDH1A1DHODHMAPTLMNA
SCHEMBL8370671 0.82 NR1H4 (0.46) NR1H4ALDH1A1DHODHMAPTLMNA
SCHEMBL7993247 0.82 KDM4E (0.43) ALDH1A1MAPTLMNAHPGDSMN1; SMN2
SCHEMBL8184192 0.82 NR1H4 (0.45) NR1H4ALDH1A1DHODHMAPTLMNA
SCHEMBL8517156 0.81 NR1H4 (0.45) NR1H4ALDH1A1DHODHMAPTLMNA
Hydrochloric Acid SCHEMBL8187880 0.81 NR1H4 (0.45) NR1H4ALDH1A1DHODHMAPTLMNA
SCHEMBL7990102 0.80 NR1H4 (0.46) NR1H4ALDH1A1MAPTLMNAHPGD
SCHEMBL7979061 0.80 PDE4D (0.39) ALDH1A1LMNASMN1; SMN2KDM4EMEN1
SCHEMBL7991365 0.78 BRPF1 (0.43) ALDH1A1MAPTLMNASMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6277861-B1 FOR TREATMENT AND PROPHYLAXIS OF NERVOUS SYSTEM DISORDERS, PSYCHOLOGICAL DISORDERS, MUSCULAR DISORDERS, DRUG ADDICTION WITHDRAWAL, PAIN SMITHKLINE BEECHAM, P.L.C. (GB) 2001-08-21 US claimed
US-6277861-B1 FOR TREATMENT AND PROPHYLAXIS OF NERVOUS SYSTEM DISORDERS, PSYCHOLOGICAL DISORDERS, MUSCULAR DISORDERS, DRUG ADDICTION WITHDRAWAL, PAIN SMITHKLINE BEECHAM, P.L.C. (GB) 2001-08-21 US disclosed
CN-1255917-A Anti-convulsant isoquinolyl-benzamide derivatives SMITHKLINE BEECHAM PLC (GB) 2000-06-07 CN disclosed
EP-0971897-A1 ANTI-CONVULSANT ISOQUINOLYL-BENZAMIDE DERIVATIVES SMITHKLINE BEECHAM PLC (GB) 2000-01-19 EP disclosed
WO-1998041507-A1 ANTI-CONVULSANT ISOQUINOLYL-BENZAMIDE DERIVATIVES SMITHKLINE BEECHAM PLC (GB) 1998-09-24 WO disclosed